<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37859501</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-7979</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><PubDate><Year>2023</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Epidemiology and psychiatric sciences</Title><ISOAbbreviation>Epidemiol Psychiatr Sci</ISOAbbreviation></Journal><ArticleTitle>COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.</ArticleTitle><Pagination><StartPage>e61</StartPage><MedlinePgn>e61</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e61</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S2045796023000719</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">It has been suggested that people with mental disorders have an elevated risk to acquire severe acute respiratory syndrome coronavirus 2 and to be disproportionally affected by coronavirus disease 19 (COVID-19) once infected. We aimed to analyse the COVID-19 infection rate, course and outcome, including mortality and long COVID, in people with anxiety, depressive, neurodevelopmental, schizophrenia spectrum and substance use disorders relative to control subjects without these disorders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study constitutes a preregistered systematic review and random-effects frequentist and Bayesian meta-analyses. Major databases were searched up until 27 June 2023.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-one original articles were included reporting 304 cross-sectional and prospective effect size estimates (median <i>n</i> per effect-size = 114837) regarding associations of interest. Infection risk was not significantly increased for any mental disorder that we investigated relative to samples of people without these disorders. The course of COVID-19, however, is relatively severe, and long COVID and COVID-19-related hospitalization are more likely in all patient samples that we investigated. The odds of dying from COVID-19 were high in people with most types of mental disorders, except for those with anxiety and neurodevelopmental disorders relative to non-patient samples (pooled ORs range, 1.26-2.57). Bayesian analyses confirmed the findings from the frequentist approach and complemented them with estimates of the strength of evidence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Once infected, people with pre-existing mental disorders are at an elevated risk for a severe COVID-19 course and outcome, including long COVID and mortality, relative to people without pre-existing mental disorders, despite an infection risk not significantly increased.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Molero</LastName><ForeName>Patricio</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9287-9635</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Clinical Psychology, Cl&#xed;nica Universidad de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reina</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4079-9753</Identifier><AffiliationInfo><Affiliation>Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Cl&#xed;nica Universidad de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blom</LastName><ForeName>Jan Dirk</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute of Psychology, Department of Clinical Psychology, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outpatient Clinic for Uncommon Psychiatric Syndromes, Parnassia Psychiatric Institute, The Hague, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Gonz&#xe1;lez</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><AffiliationInfo><Affiliation>Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER-OBN, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinken</LastName><ForeName>Aischa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Psychology, Department of Clinical Psychology, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Kloet</LastName><ForeName>E Ronald</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molendijk</LastName><ForeName>Marc L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0003-2819-0988</Identifier><AffiliationInfo><Affiliation>Institute of Psychology, Department of Clinical Psychology, Leiden University, Leiden, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Psychiatr Sci</MedlineTA><NlmUniqueID>101561091</NlmUniqueID><ISSNLinking>2045-7960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">corona virus disease</Keyword><Keyword MajorTopicYN="N">disease course</Keyword><Keyword MajorTopicYN="N">infection risk</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental disorders</Keyword><Keyword MajorTopicYN="N">substance use disorders</Keyword></KeywordList><CoiStatement>PM reports to have received research grants from the Ministry of Education (Spain), the Government of Navarra (Spain), the Spanish Foundation of Psychiatry and Mental Health, and AstraZeneca; he is a clinical consultant for MedAvanteProPhase and Worldwide Clinical Trials Limited and has received lecture honoraria from or has been a consultant for AB-Biotics, Guidepoint, Janssen, Novumed, Roland Berger, and Scienta. GR declares to have received a research grant or lecture honoraria from Roche, MSD, and GSK. The other authors report not to have any potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37859501</ArticleId><ArticleId IdType="pmc">PMC10594644</ArticleId><ArticleId IdType="doi">10.1017/S2045796023000719</ArticleId><ArticleId IdType="pii">S2045796023000719</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acuff SF, Tucker JA and Murphy JG (2020) Behavioral economics of substance use: Understanding and reducing harmful use during the COVID-19 pandemic. Experimental Clinical Psychopharmacoly 29(6), 739&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163023</ArticleId><ArticleId IdType="pubmed">33166163</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B and Xie Y (2022) Long COVID after breakthrough SARS-CoV-2 infection. Nature Medicine 28, 1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Diwani AAJ, Pollak TA, Irani SR and Lennox BR (2017) Psychosis: An autoimmune disease? Immunology 152(3), 388&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5629440</ArticleId><ArticleId IdType="pubmed">28704576</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen B, El Shahawy O, Rogers ES, Hochman S, Khan MR and Krawczyk N (2020) Association of substance use disorders and drug overdose with adverse COVID-19 outcomes in New York City: January-October 2020. Journal of Public Health (Oxford) 43(3), 462&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799011</ArticleId><ArticleId IdType="pubmed">33367823</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.</Citation></Reference><Reference><Citation>American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington, DC: American Psychiatric Association.</Citation></Reference><Reference><Citation>Amin MM, Futrawan R and Husada MS (2022) Correlation between schizophrenia and coronavirus disease in North Sumatera, Indonesia: A correlative analytical study. Frontiers in Psychiatry 13, 896623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198631</ArticleId><ArticleId IdType="pubmed">35722585</ArticleId></ArticleIdList></Reference><Reference><Citation>An C, Lim H, Kim DW, Chang JH, Choi YJ and Kim SW (2020) Machine learning prediction for mortality of patients diagnosed with COVID-19: A nationwide Korean cohort study. Scientific Reports 10(1), 18716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599238</ArticleId><ArticleId IdType="pubmed">33127965</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar KMJ, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, Brown S and Pressman AR (2020) Disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff (Millwood) 39(7), 1253&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pubmed">32437224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey LC, Razzaghi H, Burrows EK, Bunnell HT, Camacho PEF, Christakis DA, Eckrich D, Kitzmiller M, Lin SM, Magnusen BC, Newland J, Pajor NM, Ranada D, Rao S, Sofela O, Zahner J, Bruno C and Forrest CB (2021) Assessment of 135 794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States. JAMA Pediatrics 175(2), 176&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684518</ArticleId><ArticleId IdType="pubmed">33226415</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillargeon J, Polychronopoulou E, Kuo YF and Raji MA (2021) The impact of substance use disorder on COVID-19 outcomes. Psychiatric Services 72(5), 578&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089118</ArticleId><ArticleId IdType="pubmed">33138712</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker RA, Pikalov A, Tran QV, Kremenets T, Arani RB and Doraiswamy PM (2009) Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: A systematic Bayesian signal detection analysis. Psychopharmacological Bulletin 42(1), 11&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19204649</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcella CA, Polcwiartek C, Mohr GH, Hodges G, S&#xf8;ndergaard K, Bang C, Andersen MP, Fosb&#xf8;l E, K&#xf8;ber L, Schou M, Torp-Pedersen C, Kessing LV, Gislason G and Kragholm K (2021) Severe mental illness is associated with increased mortality and severe course of COVID-19. Acta Psychiatrica Scandinavica 144, 82&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250986</ArticleId><ArticleId IdType="pubmed">33894064</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton BB, Zagler A, Engl K, Rihs L and Musil R (2020) Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: Results of the Metabolism in Psychiatry (MiP) Study. European Archives of Psychiatry and Clinical Neuroscience 270(5), 597&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">31302731</ArticleId></ArticleIdList></Reference><Reference><Citation>Batey RG, Cao Q and Gould B (2002) Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27(1), 37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062635</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD and Gale CR (2021) Pre-pandemic mental illness and risk of death from COVID-19. The Lancet Psychiatry 8(3), 182&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906744</ArticleId><ArticleId IdType="pubmed">33610222</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumeister H, Hutter N and Bengel J (2012) Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Systematic Reviews 12, CD008381.</Citation><ArticleIdList><ArticleId IdType="pubmed">23235661</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayrak M and &#xc7;adirci K (2021) The associations of life quality, depression, and cognitive impairment with mortality in older adults with COVID-19: A prospective, observational study. Acta Clinica Belgica, 77(3), 588&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">33870876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Apostolo D, Alb&#xe8; A, Crevola M, Errica N, Ratano G, Tonello S, Minisini R, D&#x2019;Onghia D, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, Cappellano G, Casella S, Chiocchetti A, Clivati E, Giordano M, Manfredi M, Patti G, Pinato DJ, Puricelli C, Raineri D, Rolla R, Sainaghi PP and Pirisi M (2022) No-More COVID study group. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study. Frontiers in Immunology 13, 1038227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9807078</ArticleId><ArticleId IdType="pubmed">36601115</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E, Toups M and Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: Double trouble. Neuron 107(2), 234&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhopalwala H, Dewaswala N, Kolagatla S, Wisnieski L, Piercy J, Bhopalwala A and Moka N (2022) Predictors of mortality for patients with COVID-19 in the rural Appalachian region. International Journal of General Medicine 15, 2207&#x2013;2214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893147</ArticleId><ArticleId IdType="pubmed">35250298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramer WM, Rethlefsen ML, Kleijnen J and Franco OH (2017) Optimal database combinations for literature searches in systematic reviews: A prospective exploratory study. Systematic Reviews 6(1), 245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718002</ArticleId><ArticleId IdType="pubmed">29208034</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler SM (2021) What is the outlook for addressing social determinants of health? JAMA Health Forum 2(9), e213639&#x2013;e213639.</Citation><ArticleIdList><ArticleId IdType="pubmed">36218664</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EA (2022) Understanding Long Covid: Nosology, social attitudes and stigma. Brain Behavior and Immunology 99, 17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">34563621</ArticleId></ArticleIdList></Reference><Reference><Citation>Callus E, Bassola B, Fiolo V, Bertoldo EG, Pagliuca S and Lusignani M (2020) Stress reduction techniques for health care providers dealing with severe coronavirus infections (SARS, MERS, and COVID-19): A rapid review. Frontiers in Psychology 11, 589698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758192</ArticleId><ArticleId IdType="pubmed">33362654</ArticleId></ArticleIdList></Reference><Reference><Citation>Canal-Rivero M, Catal&#xe1;n-Barrag&#xe1;n R, Rubio-Garc&#xed;a A, Garrido-Torres N, Crespo- Facorro B, Ruiz-Veguilla M and IBIS Translational Psychiatry Group (2021) Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population. Schizophrenia Research 229, 53&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894093</ArticleId><ArticleId IdType="pubmed">33631466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantenys-Molina S, Fern&#xe1;ndez-Cruz E, Francos P, Lopez Bernaldo de Quir&#xf3;s JC, Mu&#xf1;oz P and Gil-Herrera J (2020) Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain. Clinical and Experimental Immunology 203(3), 424&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753314</ArticleId><ArticleId IdType="pubmed">33187018</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Gunning FM, McCoy TH and Perlis RH (2021) Mood disorders and outcomes of COVID-19 hospitalizations. American Journal of Psychiatry 178, 541&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">33820425</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalan A, Aymerich C, Bilbao A, Pedruzo B, P&#xe9;rez JL, Aranguren N, Salazar de Pablo G, Hedges E, Gil P, Segarra R, Gonz&#xe1;lez-Pinto A, Fern&#xe1;ndez-Rivas A, Inchausti L, McGuire P, Fusar-Poli P and Gonz&#xe1;lez-Torres M&#xc1; (2023) Psychosis and substance abuse increase the COVID-19 mortality risk. Psychological Medicine 53(9), 4236&#x2013;4244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9114752</ArticleId><ArticleId IdType="pubmed">35410632</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallaro M, Moiz H, Keeling MJ and McCarthy ND (2021) Contrasting factors associated with COVID-19-related ICU admission and death outcomes in hospitalised patients by means of Shapley values. PLoS Computational Biology 17(6), e1009121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8259985</ArticleId><ArticleId IdType="pubmed">34161326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LMW, Subramaniapillai M, Gill H, Liu RN, Joseph P, Teopiz KM, Cao B, Mansur RB, Lin K, Rosenblat JD, Ho RC and McIntyre RS (2021) Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: A systematic review and meta-analysis. JAMA Psychiatry, 78(10), 1079&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319830</ArticleId><ArticleId IdType="pubmed">34319365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cernea S, Dima L, Correll CU and Manu P (2020) Pharmacological management of glucose dysregulation in patients treated with second-generation antipsychotics. Drugs 80(17), 1763&#x2013;1781.</Citation><ArticleIdList><ArticleId IdType="pubmed">32930957</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang MH, Moonesinghe R and Truman BI (2020) COVID-19 hospitalization by race and ethnicity: Association with chronic conditions among Medicare beneficiaries, January 1-September 30, 2020. Journal of Racial and Ethnic Health Disparities 9, 325&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793388</ArticleId><ArticleId IdType="pubmed">33420609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Fernandez-Egea E, Jones PB, Lewis JR and Cardinal RN (2021a) Longer-term mortality following SARS-CoV-2 infection in people with severe mental illness: Retrospective case-matched study. British Journal of Psychiatry Open 7(6), e201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564024</ArticleId><ArticleId IdType="pubmed">34745650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z and John Wherry E (2020) T cell responses in patients with COVID-19. Nature Reviews. Immunology 20(9), 529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Jones PB, Underwood BR, Fernandez-Egea E, Qin P, Lewis JR and Cardinal RN (2021b) Risk factors for excess deaths during lockdown among older users of secondary care mental health services without confirmed COVID-19: A retrospective cohort study. International Journal of Geriatric Psychiatry 36(12), 1899&#x2013;1907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420159</ArticleId><ArticleId IdType="pubmed">34382242</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung MW (2019) A guide to conducting a meta-analysis with non-independent effect sizes. Neuropsychology Reviews 29(4), 387&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6892772</ArticleId><ArticleId IdType="pubmed">31446547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chireh B, Li M and D&#x2019;Arcy C (2019) Diabetes increases the risk of depression: A systematic review, meta-analysis and estimates of population attributable fractions based on prospective studies. Preventive Medicine Reports 14, 100822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6378921</ArticleId><ArticleId IdType="pubmed">30815337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrousos GP (2009) Stress and disorders of the stress system. Nature Reviews Endocrinology 5(7), 374&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">19488073</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N, Benger J, Khunti K, Spiegelhalter D, Sheikh A, Valabhji J, Lyons RA, Robson J, Semple MG, Kee F, Johnson P, Jebb S, Williams T and Hippisley-Cox J (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: National derivation and validation cohort study. British Medical Journal 371, m3731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574532</ArticleId><ArticleId IdType="pubmed">33082154</ArticleId></ArticleIdList></Reference><Reference><Citation>Clouston SAP, Luft BJ and Sun E (2021) Clinical risk factors for mortality in an analysis of 1375 patients admitted for COVID treatment. scientific Reports 11(1), 23414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8642440</ArticleId><ArticleId IdType="pubmed">34862487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen HA, Gerstein M, Yaniv N, Richenberg Y, Jacobson E, Marton S, Hoshen M and Shkalim Zemer V (2022) Attention-deficit/hyperactivity disorder as a risk factor for COVID-19 infection. Journal of Attention Disorders 26(7), 985&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">34668429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS and Turner RB (2012) Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences USA 109(16), 5995&#x2013;5999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341031</ArticleId><ArticleId IdType="pubmed">22474371</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Mental Disorders Collaborators (2021) Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet 398, P1700&#x2013;P1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins L, Ebyarimpa I, Cheetham N, Tzortziou Brown V, Brennan K and Panovska-Griffiths J (2021) Factors associated with COVID-19 related hospitalization, critical care admission and mortality using linked primary and secondary care data. Influenza and Other Respiratory Viruses 15(5), 577&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242436</ArticleId><ArticleId IdType="pubmed">33942510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai XJ, Shao Y, Ren L, Tao W and Wang Y (2022) Risk factors of COVID-19 in subjects with and without mental disorders. Journal of Affective Disorders 297, 102&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8526429</ArticleId><ArticleId IdType="pubmed">34687782</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies HT, Crombie IK and Tavakoli M (1998) When can odds ratios mislead? British Medical Journal 316(7136), 989&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1112884</ArticleId><ArticleId IdType="pubmed">9550961</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hert M, Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A and Peuskens J (2007) A case series: Evaluation of the metabolic safety of aripiprazole. Schizophrenia Bulletin 33(3), 823&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2526132</ArticleId><ArticleId IdType="pubmed">16940338</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kloet ER, Jo&#xeb;ls M and Holsboer F (2005) Stress and the brain: From adaptation to disease. Nature Reviews. Neuroscience 6(6), 463&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">15891777</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kloet ER, Meijer OC, de Nicola AF, de Rijk RH and Jo&#xeb;ls M (2018) Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Frontiers in Neuroendocrinology 49, 124&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">29428549</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, Medeiros MIVARC, Vilela RVR, Fernandes GR and Grenfell RFQ (2022) Long COVID-19 syndrome: A 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 116(11), 1007&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Descamps A, Frenkiel J, Zarca K, Laidi C, Godin O, Launay O, Leboyer M and Durand-Zaleski I (2022) Association between mental disorders and COVID-19 outcomes among inpatients in France: A retrospective nationwide population-based study. Journal of Psychiatric Research 155, 194&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392549</ArticleId><ArticleId IdType="pubmed">36063611</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito A, Fiore V, Princic E, Geremia N, Napodano CMP, Muredda AA, Maida I, Madeddu G and Babudieri S (2021) Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS One 16(3), e0248009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963051</ArticleId><ArticleId IdType="pubmed">33724987</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Sim&#xf3;n R, Lalueza A, Lora-Tamayo J, Rubio-Rivas M, Mendo CL, Mart&#xed;nez MLT, M&#xe9;ndez CA, Pesqueira Font&#xe1;n PM, Cruz AF, Cabrera JLR, Rodr&#xed;guez BC, Rubio AE, de &#xc1;vila VSR, Garc&#xed;a GMG, Osorio LC, Gonz&#xe1;lez-Fern&#xe1;ndez M, Noya AG, Wittel MB, Fernandez FA, Sempere VM, Artero A, Loureiro-Amigo J, Huelgas RG, Santos JMA, Lumbreras C and SEMI-COVID-19 Network (2021) Clinical characteristics and risk factors of respiratory failure in a cohort of young patients requiring hospital admission with SARS-CoV2 infection in Spain: Results of the multicenter SEMI-COVID-19 registry. Journal of General Internal Medicine 36(10), 3080&#x2013;3087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356682</ArticleId><ArticleId IdType="pubmed">34379281</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Quevedo C, Iglesias-Gonzalez M, Giralt-Lopez M, Rangil T, Sanagustin D, Moreira M, L&#xf3;pez-Ramentol M, Ib&#xe1;&#xf1;ez-Cappar&#xf3;s A, Lor&#xe1;n ME, Bustos-Cardena T, M&#xe9;nendez-Cui&#xf1;as I, Mundo-Cid P, Blanco-Presas L, de Pablo J and Cuevas-Esteban J (2021) Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients. Acta Psychiatrica Scandinavica 143(6), 526&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250711</ArticleId><ArticleId IdType="pubmed">33792912</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK and Lanct&#xf4;t KL (2010) A meta-analysis of cytokines in major depression. Biological Psychiatry 67(5), 446&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">20015486</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Peyser ND, Lin F, Knight SJ, Djibo A, Khatib R, Kitzman H, O&#x2019;Brien E, Williams N, Isasi C, Kornak J, Carton TW, Olgin JE, Pletcher MJ, Marcus GM and Beatty AL (2023) Factors associated with long COVID symptoms in an online cohort study. Open Forum Infectious Diseases 10(2), ofad047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede C, Dawson AZ, Walker RJ, Garacci E, Campbell JA and Egede LE (2021) Relationship between mental health diagnoses and COVID-19 test positivity, hospitalization, and mortality in Southeast Wisconsin. Psychological Medicine 53(3), 927&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185414</ArticleId><ArticleId IdType="pubmed">34034845</ArticleId></ArticleIdList></Reference><Reference><Citation>Feczko E, Miranda-Dominguez O, Marr M, Graham AM, Nigg JT and Fair DA (2019) The heterogeneity problem: Approaches to identify psychiatric subtypes. Trends in Cognitive sciences 23(7), 584&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821457</ArticleId><ArticleId IdType="pubmed">31153774</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca PM, Yon DK and Boyer L (2021a) Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: A systematic review and meta-analysis. JAMA Psychiatry 78(11), 1208&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317055</ArticleId><ArticleId IdType="pubmed">34313711</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Leone M, Llorca PM, Orleans V, Loundou A, Lancon C, Auquier P, Baumstarck K and Boyer L (2021b) Disparities in intensive care unit admission and mortality among patients with schizophrenia and COVID-19: A national cohort. Schizophrenia Bulletin 47(3), 624&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665717</ArticleId><ArticleId IdType="pubmed">33089862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraguas D, D&#xed;az-Caneja CM, Ayora M, Hern&#xe1;ndez-&#xc1;lvarez F, Rodr&#xed;guez-Quiroga A, Recio S, Leza JC and Arango C (2019) Oxidative stress and inflammation in first-episode psychosis: A systematic review and meta-analysis. Schizophrenia Bulletin 45(4), 742&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6581144</ArticleId><ArticleId IdType="pubmed">30169868</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis NA, Stuart B, Knight M, Vancheeswaran R, Oliver C, Willcox M, Barlow A and Moore M (2021) Predictors of clinical deterioration in patients with suspected COVID-19 managed in a &#x2018;virtual hospital&#x2019; setting: A cohort study. BMJ Open 11(3), e045356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7992373</ArticleId><ArticleId IdType="pubmed">33757955</ArticleId></ArticleIdList></Reference><Reference><Citation>Galderisi S, Heinz A, Kastrup M, Beezhold J and Sartorius N (2015) Toward a new definition of mental health. World Psychiatry 14(2), 231&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4471980</ArticleId><ArticleId IdType="pubmed">26043341</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasnier M, Choucha W, Radiguer F, Faulet T, Chappell K, Bougarel A, Kondarjian C, Thorey P, Baldacci A, Balderini M, Herrero H, Hardy-Leger I, Meyrignac O, Morin L, Lecoq A-L, Pham T, Jollant F, Monnet X, Becquemont L and Corruble E (2022) Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: A cross-sectional study. Journal of Neurology, Neurosurgery and Psychiatry 93, 1091&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pubmed">35953265</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoglou D, Meimeti E, Provatopoulou X, Stathopoulos K, Roukas KI and Galanis P (2020) Predictors of mortality in hospitalized COVID-19 patients in Athens, Greece. International Journal of Caring Sciences; Nicosia 13(3), 1689&#x2013;1698.</Citation></Reference><Reference><Citation>Glaser R and Kiecolt-Glaser JK (2015) Stress-induced immune dysfunction: Implications for health. Nature Reviews Immunology 5(3), 243&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">15738954</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger N, Bergman-Levy T, Haklai Z, Yoffe R, Davidson M, Susser E, Levi L, Elhasid T and Weiser M (2022) COVID-19 and severe mental illness in Israel: Testing, infection, hospitalization, mortality and vaccination rates in a countrywide study. Molecular Psychiatry 27(7), 3107&#x2013;3114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9028900</ArticleId><ArticleId IdType="pubmed">35459901</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant RL (2014) Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ 348, f7450.</Citation><ArticleIdList><ArticleId IdType="pubmed">24464277</ArticleId></ArticleIdList></Reference><Reference><Citation>Haimovich A, Warner F, Young HP, Ravindra NG, Sehanobish A, Gong G, Wilson FP, van Dijk D, Schulz W and Taylor RA (2020) Patient factors associated with SARS-CoV-2 in an admitted emergency department population. Journal of the American College of Emergency Physicians Open 1(4), 569&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280703</ArticleId><ArticleId IdType="pubmed">32838371</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartonen T, Jermy B, S&#xf5;najalg H, Vartiainen P, Krebs K, Vabalas A, Leino T, Nohynek H, Sivel&#xe4; J, M&#xe4;gi R, Daly M, Ollila HM, Milani L, Perola M, Ripatti S and Ganna A (2023) Nationwide health, socio-economic and genetic predictors of COVID-19 vaccination status in Finland. Nature Human Behaviour 7(7), 1069&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10365990</ArticleId><ArticleId IdType="pubmed">37081098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi-Shahri SM, Tabatabaei SMN, Ansari-Moghaddam A, Mohammadi M, Okati-Aliabad H, Tabatabaei SM, Ansari H, Abbasi M, Sheikhzadeh K, Baygi MZ, Sartipi M, Sanei-Sistani S, Khorashad ARS, Ansari-Moghadam F, Torab N, Khalili T and Miri-Aliabad G (2022) Epidemiological and clinical risk factors related to severe COVID-19 in Iran: A multi-center study. BMC Infectious Diseases 22(1), 184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864589</ArticleId><ArticleId IdType="pubmed">35197013</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt DW and Newcomer JW (2001) Hyperglycemia and antipsychotic medications. Journal of Clinical Psychiatry 62(Suppl 27), 15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11806485</ArticleId></ArticleIdList></Reference><Reference><Citation>Heck DW, Boehm U, B&#xf6;ing-Messing F, B&#xfc;rkner PC, Derks K, Dienes Z, Fu Q, Gu X, Karimova D, Kiers HAL, Klugkist I, Kuiper RM, Lee MD, Leenders R, Leplaa HJ, Linde M, Ly A, Meijerink-Bosman M, Moerbeek M, Mulder J, Palfi B, Sch&#xf6;nbrodt FD, Tendeiro JN, van den Bergh D, Van Lissa CJ, van Ravenzwaaij D, Vanpaemel W, Wagenmakers EJ, Williams DR, Zondervan-Zwijnenburg M and Hoijtink H (2022) A review of applications of the Bayes factor in psychological research. Psychological Methods 28(3), 558.</Citation><ArticleIdList><ArticleId IdType="pubmed">35298215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Granath F, Bruchfeld J, Askling J, Sj&#xf6;holm D, Fored M, F&#xe4;rnert A and Naucler P (2023) Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. Journal of Internal Medicine 293(2), 246&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9877994</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, Benoit SW, Vikse J, Berger BA, Pulvino C, Hoehn J, Rose J, Santos de Oliveira MH, Lippi G and Benoit JL (2019) The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine 59(3), 599&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">33554561</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J and Thomas J (2021) Cochrane handbook for systematic reviews of interventions 6.2. https://training.cochrane.org/handbook/current (accessed 23
July
2021).</Citation></Reference><Reference><Citation>Hirashima T, Arai T, Kitajima H, Tamura Y, Yamada T, Hashimoto S, Morishita H, Minamoto S, Kawashima K, Kashiwa Y, Kameda M, Takeshita T, Suzuki H, Matsuoka H, Yamaguchi S, Tanaka T and Nagai T (2021) Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study. Journal of Infection and Chemotherapy 27(1), 76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547613</ArticleId><ArticleId IdType="pubmed">33051144</ArticleId></ArticleIdList></Reference><Reference><Citation>Izurieta HS, Graham DJ, Jiao Y, Hu M, Lu Y, Wu Y, Chillarige Y, Wernecke M, Menis M, Pratt D, Kelman J and Forshee R (2021) Natural history of coronavirus disease 2019: Risk factors for hospitalizations and deaths among &gt;26 million US Medicare beneficiaries. The Journal of Infectious Diseases 223(6), 945&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799044</ArticleId><ArticleId IdType="pubmed">33325510</ArticleId></ArticleIdList></Reference><Reference><Citation>JASP Team (2017) JASP (version 0.16.2). https://jasp-stats.org/ (accessed 15
December
2022).</Citation></Reference><Reference><Citation>Jeon H-L, Kwon JS, Park S-H and Shin J-Y (2020) Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: A nationwide cohort study. The British Journal of Psychiatry 218(6), 344&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">33407954</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M and Price D (2021) Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmatic and Observational Research 12, 93&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Juster RP, McEwen BS and Lupien SJ (2010) Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience &amp; Biobehavioral Reviews, 35(1), 2&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19822172</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr, and Schatzberg AF (2017) HPA axis in major depression: Cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry 22(4), 527&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5313380</ArticleId><ArticleId IdType="pubmed">27528460</ArticleId></ArticleIdList></Reference><Reference><Citation>Keysers C, Gazzola V and Wagenmakers EJ (2020) Using Bayes factor hypothesis testing in neuroscience to establish evidence of absence. Nature Neuroscience 23, 788&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610527</ArticleId><ArticleId IdType="pubmed">32601411</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiecolt-Glaser JK, Derry HM and Fagundes CP (2015) Inflammation: Depression fans the flames and feasts on the heat. American Journal of Psychiatry 172(11), 1075&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511978</ArticleId><ArticleId IdType="pubmed">26357876</ArticleId></ArticleIdList></Reference><Reference><Citation>Koller EA, Cross JT, Doraiswamy PM and Schneider BS (2003) Risperidone-associated diabetes mellitus: A pharmacovigilance study. Pharmacotherapy 23(6), 735&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">12820816</ArticleId></ArticleIdList></Reference><Reference><Citation>Koller EA and Doraiswamy PM (2002) Olanzapine-associated diabetes mellitus. Pharmacotherapy 22(7), 841&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">12126218</ArticleId></ArticleIdList></Reference><Reference><Citation>Koller E, Schneider B, Bennett K and Dubitsky G (2001) Clozapine-associated diabetes. American Journal of Medicine 111(9), 716&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">11747852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreek MJ, Nielsen DA, Butelman ER and LaForge KS (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nature Neuroscience 8(11), 1450&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">16251987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundi H, &#xc7;etin EH&#xd6;, Canpolat U, Aras S, Celik O, Ata N, Birinci S, &#xc7;ay S, &#xd6;zeke &#xd6;, Tanbo&#x11f;a IH and Topalo&#x11f;lu S (2020) The role of frailty on adverse outcomes among older patients with COVID-19. Journal of Infection 81(6), 944&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521439</ArticleId><ArticleId IdType="pubmed">33002560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, Damant RW, Ferrara G, Lim RK, Stickland MK, Ogando NS, Power C and Smith MP (2023) Characterizing long-COVID brain fog: A retrospective cohort study. Journal of Neurology 270, 4640&#x2013;4646.</Citation><ArticleIdList><ArticleId IdType="pubmed">37555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers F, Milaneschi Y, de Jonge P, Giltay EJ and Penninx BWJH (2018) Metabolic and inflammatory markers: Associations with individual depressive symptoms. Psychological Medicine 48(7), 1102&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">28889804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebin JA, Mudan A and Wu AHB (2020) Chronic alcohol use does not protect against COVID-19 infection. American Journal of Emergency Medicine 45, 640&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666530</ArticleId><ArticleId IdType="pubmed">33221114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW, Yang JM, Moon SY, Kim N, Ahn YM, Kim JM, Shin JI, Suh DI, Yon DK and Study Authors (2021) Association between mental illness and COVID-19 in South Korea: A post-hoc analysis. The Lancet Psychiatry 8(4), 271&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906626</ArticleId><ArticleId IdType="pubmed">33617761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW, Yang JM, Moon SY, Yoo IK, Ha EK, Kim SY, Park UM, Choi S, Lee SH, Ahn YM, Kim JM, Koh HY and Yon DK (2020) Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: A nationwide cohort study. The Lancet Psychiatry 7(12), 1025&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498216</ArticleId><ArticleId IdType="pubmed">32950066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lega I, Nistic&#xf2; L, Palmieri L, Caroppo E, Lo Noce C, Donfrancesco C, Vanacore N, Scattoni ML, Picardi A, Gigantesco A, Brusaferro S and Onder G (2021) Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy. EClinicalMedicine 35, 100854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8062162</ArticleId><ArticleId IdType="pubmed">33907730</ArticleId></ArticleIdList></Reference><Reference><Citation>Libowitz MR and Nurmi EL (2021) The burden of antipsychotic-induced weight gain and metabolic syndrome in children. Frontiers in Psychiatry 12, 623681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994286</ArticleId><ArticleId IdType="pubmed">33776816</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Lu H and Zhang W (2020) Clinical observation and management of COVID-19 patients. Emerging Microbes and Infections 9(1), 687&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103696</ArticleId><ArticleId IdType="pubmed">32208840</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zhang L, Cai S, Lu Z, Bao W, Guo Z and Rong S (2022) Association of mental health with clinical outcomes in hospitalized patients with moderate COVID-19. Journal of Affective Disorders Affect Disord 312, 331&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098941</ArticleId><ArticleId IdType="pubmed">35577158</ArticleId></ArticleIdList></Reference><Reference><Citation>Logette E, Lorin C, Favreau C, Oshurko E, Coggan JS, Casalegno F, Sy MF, Monney C, Bertschy M, Delattre E, Fonta PA, Krepl J, Schmidt S, Keller D, Kerrien S, Scantamburlo E, Kaufmann AK and Markram H (2021) A machine-generated view of the role of blood glucose levels in the severity of COVID-19. Front Public Health 9, 695139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356061</ArticleId><ArticleId IdType="pubmed">34395368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboub N, Rizk R, Karavetian M and de Vries N (2021) Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: A narrative review. Nutrition Reviews 79, 627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114851</ArticleId><ArticleId IdType="pubmed">32974658</ArticleId></ArticleIdList></Reference><Reference><Citation>Maripuu M, Bendix M, &#xd6;hlund L, Widerstr&#xf6;m M and Werneke U (2021) Death associated with coronavirus (COVID-19) infection in individuals with severe mental disorders in Sweden during the early months of the outbreak-an exploratory cross-sectional analysis of a population-based register study. Frontiers in Psychiatry 11, 609579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819873</ArticleId><ArticleId IdType="pubmed">33488430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazereel V, Van Assche K, Detraux J and De Hert M (2021) COVID-19 vaccination for people with severe mental illness: Why, what, and how? The Lancet Psychiatry 8(5), 444&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906686</ArticleId><ArticleId IdType="pubmed">33548184</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy JP, Citrome L, Hernandez D, Cucchiaro J, Hsu J, Pikalov A and Loebel A (2013) Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: A randomized, 6-week, open-label study. Journal of Clinical Psychiatry 74(2), 170&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">23473350</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen BS (2013) Allostasis and allostatic load: implications for neuropsychopharmacology. Stress and the Brain, 2&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">10649824</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre RS, Soczynska JK, Konarski JZ and Kennedy SH (2006) The effect of antidepressants on glucose homeostasis and insulin sensitivity: Synthesis and mechanisms. Expert Opinion on Drug Safety 5(1), 157&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">16370964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mena G, Martinez PP, Mahmud AS, Marquet PA, Buckee CO and Santillana M (2021) Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science 372(6545), eabg5298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158961</ArticleId><ArticleId IdType="pubmed">33906968</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, Manor I, Rotem A, Schneider T, Vinker S, Golan Cohen A, Lauden A, Weizman A and Green I (2020) ADHD as a risk factor for infection with Covid-19. Journal of Attention Disorders 25(13), 1783&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427814</ArticleId><ArticleId IdType="pubmed">32697120</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E, Weiss MD, Cortese S, Rotem A, Schneider T, Craig SG, Vinker S, Golan A, Green I, Ashkenazi S, Weizman A and Manor I (2021) The Association between ADHD and the Severity of COVID-19 Infection. Journal of Attention Disorders 26(4), 491&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">33797281</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG and PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS medicine 6(7), e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M, Berk M, Carvalho AF and Puri BK (2020) Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders. European Psychiatry 63(1), e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057392</ArticleId><ArticleId IdType="pubmed">32093791</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller N and Schwarz MJ (2010) Immune system and schizophrenia. Current Immunology Reviews 6(3), 213&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2971548</ArticleId><ArticleId IdType="pubmed">21057585</ArticleId></ArticleIdList></Reference><Reference><Citation>Musheyev B, Janowicz R, Borg L, Matarlo M, Boyle H, Hou W and Duong TQ (2021) Characterizing non-critically ill COVID-19 survivors with and without in-hospital rehabilitation. Scientific Reports 11(1), 21039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8548441</ArticleId><ArticleId IdType="pubmed">34702883</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemani K, Conderino S, Marx J, Thorpe LE and Goff DC (2021b) Association between antipsychotic use and COVID-19 mortality among people with serious mental illness. JAMA Psychiatry 78(12), 1391&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459305</ArticleId><ArticleId IdType="pubmed">34550323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemani K, Li C, Olfson M, Blessing EM, Razavian N, Chen J, Petkova E and Goff DC (2021a) Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatry 78(4), 380&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841576</ArticleId><ArticleId IdType="pubmed">33502436</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson SF, Laursen TM, Osler M, Hjorth&#xf8;j C, Benros ME, Ethelberg S, M&#xf8;lbak K and Nordentoft M (2022) Adverse SARS-CoV-2-associated outcomes among people experiencing social marginalisation and psychiatric vulnerability: A population-based cohort study among 4,4 million people. The Lancet Regional Health Europe 20, 100421&#x2013;100421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242846</ArticleId><ArticleId IdType="pubmed">35789954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimi K, Neylan TC, Bertenthal D, Seal KH and O&#x2019;Donovan A (2022) Association of psychiatric disorders with incidence of SARS-CoV-2 breakthrough infection among vaccinated adults. JAMA Network Open 5(4), e227287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011123</ArticleId><ArticleId IdType="pubmed">35420660</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando V, Rea F, Savar&#xe9; L, Guarino I, Mucherino S, Perrella A, Trama U, Coscioni E, Menditto E and Corrao G (2021) Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy. PLoS One 16(1), e0237202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816996</ArticleId><ArticleId IdType="pubmed">33471809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai N and Vella SL (2022) The physical and mental health consequences of social isolation and loneliness in the context of COVID-19. Current Opinion in Psychiatry 35(5), 305&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">35787541</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R and Bhadada SK (2020) COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetology &amp; Metabolic Syndrome 14(4), 513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202837</ArticleId><ArticleId IdType="pubmed">32388331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavarin RM, Fabbri C and De Ronchi D (2022) COVID-19 hospitalization rates in individuals with substance or alcohol use disorders. Psychiatry Research 311, 114521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8934434</ArticleId><ArticleId IdType="pubmed">35338951</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Araluce R, Martinez-Gonzalez MA, Fern&#xe1;ndez-L&#xe1;zaro CI, Bes-Rastrollo M, Gea A and Carlos S (2021) Mediterranean diet and the risk of COVID-19 in the &#x2018;Seguimiento Universidad de Navarra&#x2019; cohort. Clinical Nutrition 41(12), 3061&#x2013;3068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047333</ArticleId><ArticleId IdType="pubmed">33934925</ArticleId></ArticleIdList></Reference><Reference><Citation>Poblador-Plou B, Carmona-P&#xed;rez J, Ioakeim-Skoufa I, Poncel-Falc&#xf3; A, Bliek-Bueno K, Cano-Del Pozo M, Gimeno-Feli&#xfa; LA, Gonz&#xe1;lez-Rubio F, Aza-Pascual-Salcedo M, Bandr&#xe9;s-Liso AC, D&#xed;ez-Manglano J, Marta-Moreno J, Mucherino S, Gimeno-Miguel A, Prados-Torres A and EpiChron Group (2020) Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: Results from the PRECOVID study in Spain. International Journal of Environmental Research and Public Health 17(14), 5171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400393</ArticleId><ArticleId IdType="pubmed">32709002</ArticleId></ArticleIdList></Reference><Reference><Citation>Qeadan F, Tingey B, Bern R, Porucznik CA, English K, Saeed AI and Madden EF (2021) Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data. EClinicalMedicine 37, 100938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8177438</ArticleId><ArticleId IdType="pubmed">34109308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi R, Cerda IH, ElTohamy A, Chen JA, Stevens C and Liu CH (2023) Long COVID and psychological distress in young adults: Potential protective effect of a prior mental health diagnosis. Journal of Affective Disorders 340, 639&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">37553019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Molinero A, G&#xe1;lvez-Barr&#xf3;n C, Mi&#xf1;arro A, Macho O, L&#xf3;pez GF, Robles MT, Dapena MD, Mart&#xed;nez S, Mil&#xe0; R&#xe0;fols N, Monaco EE, Hidalgo Garc&#xed;a A and COVID-19 Research Group of CSAPG (2020) Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PLoS One 15(10), e0239571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561079</ArticleId><ArticleId IdType="pubmed">33057443</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopan S and Larsen ER (2017) Use of antidepressants in patients with depression and comorbid diabetes mellitus: A systematic review. Acta Neuropsychiatrica 29(3), 127&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27776567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacher J, Mossaheb N, Spindelegger C, Klein N, Geiss-Granadia T, Sauermann R, Lackner E, Joukhadar C, M&#xfc;ller M and Kasper S (2008) Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers. Neuropsychopharmacology 33(7), 1633&#x2013;1641.</Citation><ArticleIdList><ArticleId IdType="pubmed">17712347</ArticleId></ArticleIdList></Reference><Reference><Citation>Saddichha S, Manjunatha N, Ameen S and Akhtar S (2008) Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study. Schizophrenia Research 101(1&#x2013;3), 266&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">18262771</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatore M, Gu T, Mack JA, Sankar SP, Patil S, Valley TS, Singh K, Nallamothu BK, Kheterpal S, Lisabeth L, Fritsche LG and Mukherjeea B (2021) A Phenome-Wide Association Study (PheWAS) of COVID-19 outcomes by race using the electronic health records data in michigan medicine. Journal of Clinical Medicine 10(7), 1351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8037108</ArticleId><ArticleId IdType="pubmed">33805886</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieber LZ, Dunphy C, Schieber RA, Lopes-Cardozo B, Moonesinghe R and Guy GP Jr, (2023) Hospitalization associated with comorbid psychiatric and substance use disorders among adults with COVID-19 Treated in US emergency departments from April 2020 to August 2021. JAMA Psychiatry 80(4), 331&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932946</ArticleId><ArticleId IdType="pubmed">36790774</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon FAJ, Schenk M, Palm D, Faltraco F and Thome J (2021) The collateral damage of the COVID-19 outbreak on mental health and psychiatry. International Journal of Environmental Research and Public Health 18(9), 4440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8122618</ArticleId><ArticleId IdType="pubmed">33922054</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson GM, Glick ID, Weiden PJ, Romano SJ and Siu CO (2004) Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. American Journal of Psychiatry 161(10), 1837&#x2013;1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">15465981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Kostov B, Mas-Heredia M, Vilanova-Rotllan S, Sequeira-Aymar E, Sans-Corrales M, Sant-Arderiu E, Cayuelas-Redondo L, Mart&#xed;nez-P&#xe9;rez A, Garc&#xed;a-Plana N, Anguita-Guimet A and Benavent-&#xc0;reu J (2020) Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona. PLoS One 15(8), e0237960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444503</ArticleId><ArticleId IdType="pubmed">32822413</ArticleId></ArticleIdList></Reference><Reference><Citation>Smadi M, Kaburis M, Schnapper Y, Reina G, Molero P and Molendijk ML (2023) SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: Systematic review with frequentist and Bayesian meta-analyses. British Journal of Psychiatry 223(2), 348&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">37183681</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis J, Franco-Paredes C, Henao-Mart&#xed;nez AF, Krsak M and Zimmer SM (2020) Structural vulnerability in the U.S. revealed in three waves of COVID-19. American Journal of Tropical Medicine and Hygiene 103(1), 25&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263522</ArticleId><ArticleId IdType="pubmed">32383432</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer C, Barnow S, V&#xf6;lzke H, John U, Freyberger HJ and Grabe HJ (2009) Trauma, posttraumatic stress disorder, and physical illness: Findings from the general population. Psychosomatic Medicine 71(9), 1012&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pubmed">19834051</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp (2021) Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC.</Citation></Reference><Reference><Citation>Sterne JA, Bradburn MJ and Egger M (2001) Meta&#x2012;Analysis in Stata&#x2122;. Systematic Reviews in Health Care: Meta&#x2010;analysis in Context. New York City: John Wiley &amp; Sons, 347&#x2013;369.</Citation></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB (2000) Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15), 2008&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Suran M (2023) Long COVID linked with unemployment in new analysis. Journal of the American Medical Association 329(9), 701&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">36790796</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang O, Bigelow BF, Sheikh F, Peters M, Zenilman JM, Bennett R and Katz MJ (2020) Outcomes of nursing home COVID-19 patients by initial symptoms and comorbidity: Results of universal testing of 1970 residents. Journal of the American Medical Directors Association 21(12), 1767&#x2013;1773.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556822</ArticleId><ArticleId IdType="pubmed">33153910</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR and Harrison PJ (2021) Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry 8(2), 130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira AL, Krause TM, Ghosh L, Shahani L, Machado-Vieira R, Lane SD, Boerwinkle E and Soares JC (2020) Analysis of COVID-19 infection and mortality among patients with psychiatric disorders. JAMA Network Open 4(11), e2134969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611476</ArticleId><ArticleId IdType="pubmed">34812848</ArticleId></ArticleIdList></Reference><Reference><Citation>The International Schizophrenia Consortium (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256), 748&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3912837</ArticleId><ArticleId IdType="pubmed">19571811</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, Di Gessa G, Bowyer RCE, Northstone K, Hou B, Green MJ, Dodgeon B, Doores KJ, Duncan EL, Williams FMK, OpenSAFELY Collaborative, Steptoe A, Porteous DJ, McEachan RRC, Tomlinson L, Goldacre B, Patalay P, Ploubidis GB, Katikireddi SV, Tilling K, Rentsch CT, Timpson NJ, Chaturvedi N and Steves CJ (2022) Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications 13(1), 3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Toben C and Baune BT (2015) An act of balance between adaptive and maladaptive immunity in depression: A role for T lymphocytes. Journal of Neuroimmune Pharmacology 10(4), 595&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">26133121</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda Y, Barnett PB, Sanji S, Takaizumi Y, Tomono M, Tokuda H, Taniguchi K and Shibuya K (2023) Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan. General Hospital Psychiatry 82, 1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894824</ArticleId><ArticleId IdType="pubmed">36868102</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubasi AA, AbuAnzeh RB, Tawileh HBA, Aldebei RH and Alryalat SAS (2021) A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders. Psychiatry Research 299, 113856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7927594</ArticleId><ArticleId IdType="pubmed">33740483</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzur-Bitan D, Krieger I, Kridin K, Komantscher D, Scheinman Y, Weinstein O, Cohen AD, Cicurel AA and Feingold D (2021) COVID-19 prevalence and mortality among schizophrenia patients: A large-scale retrospective cohort study. Schizophrenia Bulletin 47, 1211&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928567</ArticleId><ArticleId IdType="pubmed">33604657</ArticleId></ArticleIdList></Reference><Reference><Citation>United States National Institutes of Health (2021) Quality assessment tool for cross-sectional studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (accessed 14
July
2023).</Citation></Reference><Reference><Citation>Vai B, Mazza MG, Delli Colli C, Foiselle M, Allen B, Benedetti F, Borsini A, Casanova Dias M, Tamouza R, Leboyer M, Benros ME, Branchi I, Fusar-Poli P and De Picker LJ (2021) Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: A systematic review and meta-analysis. The Lancet Psychiatry 8(9), 797&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285121</ArticleId><ArticleId IdType="pubmed">34274033</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Meer D, Pinz&#xf3;n-Espinosa J, Lin BD, Tijdink JK, Vinkers CH, Guloksuz S and Luykx JJ (2020) Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: Findings from a population-based study. BJPsych Open 6(5), e87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417998</ArticleId><ArticleId IdType="pubmed">32696734</ArticleId></ArticleIdList></Reference><Reference><Citation>van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A and Peuskens J (2008) Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry 69(3), 472&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">18348593</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela Rodr&#xed;guez C, Arias Horcajadas F, Mart&#xed;n-Arriscado Arroba C, Combarro Ripoll C, Juanes Gonzalez A, Esperesate Pajares M, Rodrigo Holgado I, Cadenas Mance&#xf1;ido &#xc1;, S&#xe1;nchez Rodr&#xed;guez L, Baselga Penalva B, Mar&#xed;n M and Rubio G (2021) COVID-19-related neuropsychiatric symptoms in patients with alcohol abuse conditions during the SARS-CoV-2 pandemic: A retrospective cohort study using real world data from electronic health records of a tertiary hospital. Frontiers in Neurology 12, 630566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966461</ArticleId><ArticleId IdType="pubmed">33746884</ArticleId></ArticleIdList></Reference><Reference><Citation>Vel&#xe1;squez Garc&#xed;a HA, Wilton J, Smolina K, Chong M, Rasali D, Otterstatter M, Rose C, Prystajecky N, David S, Galanis E, McKee G, Krajden M and Janjua NZ (2021) Mental health and substance use associated with hospitalization among people with COVID-19: A population-based cohort study. Viruses 13(11), 2196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624346</ArticleId><ArticleId IdType="pubmed">34835002</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrotsou K, Rotaeche R, Mateo-Abad M, Mach&#xf3;n M and Vergara I (2021) Variables associated with COVID-19 severity: An observational study of non-paediatric confirmed cases from the general population of the Basque Country, Spain. British Medical Journal Open 11(4), e049066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8024058</ArticleId><ArticleId IdType="pubmed">33795313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang PW, Ahorsu DK, Lin CY, Chen IH, Yen CF, Kuo YJ, Griffiths MD and Pakpour AH (2021) Motivation to have COVID-19 vaccination explained using an extended protection motivation theory among university students in China: the role of information sources. Vaccines, 9(4), 380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070343</ArticleId><ArticleId IdType="pubmed">33924604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QQ, Kaelber DC, Xu R and Volkow ND (2021c) COVID-19 risk and outcomes in patients with substance use disorders: Analyses from electronic health records in the United States. Molecular Psychiatry 26(1), 30&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488216</ArticleId><ArticleId IdType="pubmed">32929211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu D, Li X, Liu Y and Wu Y (2021d) Antidepressants use and the risk of type 2 diabetes mellitus: A systematic review and meta-analysis. Journal of Affective Disorders 287, 41&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, Kang JH, Weisskopf MG, Branch-Elliman W and Roberts AL (2022b) Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry 79(11), 1081&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Ding M, Kang JH, Koenen KC, Kubzansky LD, Branch-Elliman W, Chavarro JE and Roberts AL (2022c) Depression, worry, and loneliness are associated with subsequent risk of hospitalization for COVID-19: A prospective study. Psychological Medicine 19, 1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9924056</ArticleId><ArticleId IdType="pubmed">35586906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang Q, Davis PB, Volkow ND and Xu R (2022a) Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry 21(1), 124&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661963</ArticleId><ArticleId IdType="pubmed">34612005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QQ, Xu R and Volkow ND (2021a) Increased risk of COVID-19 infection and mortality in people with mental disorders: Analysis from electronic health records in the United States. World Psychiatry 20(1), 124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675495</ArticleId><ArticleId IdType="pubmed">33026219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Yang Y, Ren L, Shao Y, Tao W and Dai XJ (2021b) Preexisting mental disorders increase the risk of COVID-19 infection and associated mortality. Frontiers in Public Health 9, 684112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381336</ArticleId><ArticleId IdType="pubmed">34434913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei ZX, Chen L, Zhang JJ and Cheng Y (2020) Aberrations in peripheral inflammatory cytokine levels in substance use disorders: A meta-analysis of 74 studies. Addiction 115(12), 2257&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">32533781</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch C and for the Geriatric Medicine Research Collaborative; Covid Collaborative (2021) Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: Results of an international multi-center study. Age and Ageing 50(3), 617&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929433</ArticleId><ArticleId IdType="pubmed">33543243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohleb ES, Franklin T, Iwata M and Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nature Reviews Neuroscience 17(8), 497&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">27277867</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (1992) International Statistical Classification of Disease and Related Health Problems, Tenth Revision (ICD-10). Geneva: World Health Organization.</Citation></Reference><Reference><Citation>World Health Organization (2022) WHO COVID-19 dashboard. https://covid19.who.int (accessed 24
September
2022).</Citation></Reference><Reference><Citation>World Health Organization (2023) Meeting of the international health regulations emergency committee. https://www.who.int/news/item/30-01-2023-statement-on-the-fourteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic (accessed 3
August
2023).</Citation></Reference><Reference><Citation>Yang H, Chen W, Hu Y, Chen Y, Zeng Y, Sun Y, Ying Z, He J, Qu Y, Lu D, Fang F, Valdimarsd&#xf3;ttir UA and Song H (2020) Pre-pandemic psychiatric disorders and risk of COVID-19: A UK Biobank cohort analysis. The Lancet Healthy Longevity 1(2), e69&#x2013;e79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832159</ArticleId><ArticleId IdType="pubmed">33521769</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Li W, Zhang Q, Zhang L, Cheung T, Ng CH and Xiang YT (2021) Should people with severe mental illness be prioritized for the COVID-19 vaccination? International Journal of Biological Sciences 17(6), 1443&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071759</ArticleId><ArticleId IdType="pubmed">33907507</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanover C, Mizrahi B, Kalkstein N, Marcus K, Akiva P, Barer Y, Shalev V and Chodick G (2020) What factors increase the risk of complications in SARS-CoV-2&#x2013;infected patients? A cohort study in a Nationwide Israeli Health Organization. JMIR Public Health and Surveillance 6(3), e20872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7451109</ArticleId><ArticleId IdType="pubmed">32750009</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Yao H and Larsson SC (2020) Associations of cigarette smoking with psychiatric disorders: Evidence from a two-sample Mendelian randomization study. Scientific Reports 10(1), 13807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427799</ArticleId><ArticleId IdType="pubmed">32796876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM and Correll CU (2013) Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: A systematic review and meta-analysis. International Journal of Neuropsychopharmacoly 16(6), 1205&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3594563</ArticleId><ArticleId IdType="pubmed">23199972</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J and Yu KF (1998) What&#x2019;s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280(19), 1690&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">9832001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>